Can-Fite BioPharma Ltd. (CANF) Financial Metrics
This dashboard provides comprehensive financial metrics and analysis to help evaluate Can-Fite BioPharma Ltd.'s investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.
Financial Metrics Score
Valuation Metrics
Sector benchmarks: Industrials
P/E Ratio
-1.46
Burn Risk
P/B Ratio
2.77
Strong
WeakModerateStrong
Earnings Yield
-68.57%
Yield Gap
Profitability Health
2025Return on Equity
-190.21%
Weak
WeakModerateStrong
Operating Margin
-2456.79%
Weak
WeakModerateStrong
Net Profit Margin
-2426.67%
Weak
WeakModerateStrong
Growth Indicators
2025Revenue Growth
-39.43%
Weak
WeakModerateStrong
Net Income Growth
-25.71%
Weak
WeakModerateStrong
EPS Growth
-1013.89%
Weak
WeakModerateStrong
Efficiency & Liquidity
2025Current Ratio
3.46
Strong
WeakModerateStrong
Quick Ratio
3.46
Strong
WeakModerateStrong
Asset Turnover
0.05x
Weak
WeakModerateStrong
Inventory Turnover
-
No data
Cash Flow & Resilience
Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes
Free Cash Flow Yield
-62.45%
Weak
WeakModerateStrong
EV / Free Cash Flow
-1.04x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.51x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
0.988
Strong
WeakModerateStrong
Return on Invested Capital
-1.57%
Weak
WeakModerateStrong
Cash Conversion Cycle
-16253.58 days
Strong
WeakModerateStrong
Fortress screener guardrails
2/4 passing
- FCF Yield > 3%
- Net Debt / EBITDA < 1.5x
- ROIC > 20%
- Cash Conversion Cycle < 0 days
Financial Statements
Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for CANF.
View Financial Statements